| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
|
Clin Cancer Res
|
2001
|
1.01
|
|
2
|
Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study.
|
Clin Oncol (R Coll Radiol)
|
2005
|
0.91
|
|
3
|
Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma.
|
Br J Haematol
|
2001
|
0.91
|
|
4
|
Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts.
|
Blood
|
1997
|
0.88
|
|
5
|
Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature.
|
Am J Nephrol
|
2001
|
0.87
|
|
6
|
Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma.
|
Bone Marrow Transplant
|
2005
|
0.82
|
|
7
|
The possible etiology of the vibratory systolic murmur.
|
Clin Cardiol
|
1987
|
0.82
|
|
8
|
Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel.
|
Ann Oncol
|
1999
|
0.80
|
|
9
|
Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cells.
|
Clin Cancer Res
|
1999
|
0.78
|
|
10
|
The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer.
|
Cancer Chemother Pharmacol
|
2001
|
0.77
|
|
11
|
Thrombocytopenia caused by isotretinoin.
|
S Afr Med J
|
1986
|
0.77
|
|
12
|
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
|
Bone Marrow Transplant
|
2002
|
0.76
|
|
13
|
High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.
|
Bone Marrow Transplant
|
1998
|
0.76
|
|
14
|
Arsine gas poisoning: the importance of exchange transfusions in severe cases.
|
Br J Ind Med
|
1986
|
0.75
|
|
15
|
Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.
|
Clin Exp Immunol
|
2012
|
0.75
|
|
16
|
Mitoxantrone, methotrexate, and 5-fluorouracil combination chemotherapy as first-line treatment in stage IV breast cancer.
|
Cancer
|
1986
|
0.75
|
|
17
|
Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
|
J Hematother
|
1997
|
0.75
|
|
18
|
Treatment of hairy cell leukaemia with recombinant alpha-interferon.
|
S Afr Med J
|
1987
|
0.75
|
|
19
|
Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer.
|
S Afr Med J
|
1987
|
0.75
|
|
20
|
Tandem transplantation in lymphoma.
|
Bone Marrow Transplant
|
2001
|
0.75
|
|
21
|
Eosinophilic gastro-enteritis - a complication of schistosomiasis and peripheral eosinophilia? A case report and review of the pathogenesis.
|
S Afr Med J
|
1982
|
0.75
|
|
22
|
True idiopathic splenomegaly--a distinct clinical entity.
|
Scand J Haematol
|
1986
|
0.75
|
|
23
|
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer.
|
Bone Marrow Transplant
|
2007
|
0.75
|
|
24
|
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
|
J Hematother Stem Cell Res
|
1999
|
0.75
|
|
25
|
Use of aminoglutethimide for the treatment of advanced breast cancer. Clinical correlations with previous treatment, oestrogen-receptor and menstrual status.
|
S Afr Med J
|
1987
|
0.75
|
|
26
|
Praziquantel in the acute porphyrias.
|
S Afr Med J
|
1986
|
0.75
|
|
27
|
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
|
J Neurooncol
|
1999
|
0.75
|